VIRTUAL CONFERENCE 2021
MONDAY 1ST MARCH
Professor Flora Peyvandi, University of Milan, Italy.
Flora Peyvandi is a Professor of Internal Medicine at the University of Milan, Italy. She is the Director of the Internal Medicine – Hemostasis and Thrombosis Unit of the IRCCS Maggiore Hospital and Director of the Angelo Bianchi Bonomi, Hemophilia and Thrombosis Center of Milan, Italy. Her research has been focused on the investigation of molecular mechanisms of coagulation disorders and on the immunogenicity of coagulation products. Her additional research work is focused on the prevalence and mechanism of coagulation disorders aims at developing cost-effective treatment for the widespread treatment of patients. She is President-elect of the International Society of Thrombosis and Haemostasis (ISTH), President of the European Association for Haemophilia and Allied Disorders (EAHAD), Member of the VWD & Rare Bleeding Disorders and of the Coagulation Product Safety, Supply and Access (CPSSA) Committees of the World Federation of Hemophilia (WFH), Member and Chairperson of the Medical Advisory Group of the European Hemophilia Consortium (EHC). She is also member of the Technical Health Committee of the Italian Ministry of Health. She is ad hoc Reviewer for several international journals and Associate Editor of “Journal of Thrombosis and Hemostasis” and “Orphanet Journal of Rare Diseases”. Prof. Peyvandi has authored and co-authored more than 500 scientific publications (IF: 2462,050 (1996-2020), Google Scholar H-index: 74).
Professor David Lillicrap, Queen’s University, Kingston, Canada
David Lillicrap is a Professor in the Department of Pathology and Molecular Medicine at Queen’s University, Kingston, Canada. He is the recipient of a Senior Canada Research Chair in Molecular Hemostasis. In 2013, he was elected to the Fellowship of the Royal Society of Canada. Dr. Lillicrap is a past member of the World Federation of Hemophilia’s (WFH) Medical Advisory Board and a past Chair of the WFH’s Research Committee. He is a past Chairman of the International Society on Thrombosis and Haemostasis’ (ISTH) Scientific and Standardization Committee and a current member of the Council of ISTH. Between 2008-20014 he served as an Associate Editor of Blood and is currently Co-Editor-in-Chief of the Journal of Thrombosis and Haemostasis. Dr. Lillicrap’s research interests are centered on molecular aspects of the hemostatic system, with a particular emphasis on the potential of molecular genetics and molecular biology to address questions relating to pathological hemostasis. The main foci of interest of his research group are the investigation of the immune response to FVIII, the development and evaluation of novel therapies for hemophilia A, and characterization of the biology and pathobiology of von Willebrand factor.